Novartis to invest $75 million in start-up Poseida
Poseida Therapeutics Raises $142 Million in Series C Financing
25-Apr-2019 -
Poseida Therapeutics Inc. announced closing of a Series C financing round, raising $142 million led by a $75 million equity investment from Novartis Pharma AG, and joined by several new investors including Aisling Capital Management, Pentwater Capital Management, Perceptive Advisors as well as ...